Get Live Data

Andrada Mining acquisition elevates the miner to emerging mid-tier status. Watch the video here.

Less Ads, More Data, More Tools Register for FREE
Tribe Technology set to deliver healthy pipeline of orders from Tier-One miners
Tribe Technology set to deliver healthy pipeline of orders from Tier-One minersView Video
Andrada Mining acquisition elevates the miner to emerging mid-tier status
Andrada Mining acquisition elevates the miner to emerging mid-tier statusView Video

Latest Share Chat

  2. Share Prices
  3. Genus Share Price
  4. Genus Share News
  5. UK earnings, trading statements calendar - next 7 days

Pin to quick picksGenus Share News (GNS)

Genus Information

Share Price Information for Genus (GNS)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,650.00
Bid: 1,658.00
Ask: 1,662.00
Change: -38.00 (-2.25%)
Spread: 4.00 (0.241%)
Open: 1,660.00
High: 1,694.00
Low: 1,650.00
Prev. Close: 1,688.00
GNS Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UK earnings, trading statements calendar - next 7 days

Thu, 15th Feb 2024 14:42

Friday 16 February 
NatWest Group PLCFull Year Results
Segro PLCFull Year Results
TBC Bank Group PLCFull Year Results
Monday 19 February 
Bank of Cyprus Holdings PLCFull Year Results
MoneySupermarket.com PLCFull Year Results
Transense Technologies PLCHalf Year Results
Wilmington PLCHalf Year Results
Tuesday 20 February 
Antofagasta PLCFull Year Results
Barclays PLCFull Year Results
BHP Group LtdHalf Year Results
Coca-Cola Europacific Partners PLCFull Year Results
Gran Tierra Energy IncFull Year Results
InterContinental Hotels Group PLCFull Year Results
Petra Diamonds LtdHalf Year Results
Springfield Properties PLCHalf Year Results
Wednesday 21 February 
BAE Systems PLCFull Year Results
Conduit Holdings LtdFull Year Results
Glencore PLCFull Year Results
HSBC Holdings PLCFull Year Results
Rio Tinto PLCFull Year Results
Riverstone Credit Opportunities Income PLCFull Year Results
Tate & Lyle PLCTrading Statement
Thursday 22 February 
Anglo American PLCFull Year Results
Genus PLCHalf Year Results
Hargreaves Lansdown PLCHalf Year Results
Hays PLCHalf Year Results
Hikma Pharmaceuticals PLCFull Year Results
Indivior PLCFull Year Results
Jupiter Fund Management PLCFull Year Results
Lloyds Banking Group PLCFull Year Results
ME Group International PLCFull Year Results
Morgan Sindall Group PLCFull Year Results
Pantheon International PLCHalf Year Results
Rolls-Royce Holdings PLCFull Year Results
WPP PLCFull Year Results
  
Comments and questions to newsroom@alliancenews.com
  
A full 21-day events calendar is provided each day with a subscription to Alliance News UK Professional.
  
Copyright 2024 Alliance News Ltd. All Rights Reserved.

More News
4 Sep 2012 07:14

US drought may slow demand for Genus's services

Record results from Genus, the animal genetics company, topped full-year sales and profits expectations but this year may prove tougher as farmers deal with the effects of the US drought. Revenue in the year to June 30th rose 10%, or 12% in constant currency (CC) terms, to £341.8m from £309.9m the

Read more
3 Sep 2012 16:34

Tuesday preview: Genus, Dechra, Greene King

Tuesday has a bit of an agricultural feel to it, with animal genetics company Genus and veterinary health-care company Dechra Pharmaceuticals set to update the market. Peel Hunt says emerging markets growth should be offsetting higher feed prices at Genus. It is forecasting a 15% improvement in pr

Read more
31 Aug 2012 09:48

Week Ahead: Central banks, Morrisons, Genus

Central bank decisions will be in focus next week, particularly in the wake of the central bankers' economic symposium in Jackson Hole. Indeed, so busy is European Central Bank (ECB) President Mario Draghi preparing for next week's meeting that he has been unable to attend the jolly-up in the Wyomi

Read more
31 Jul 2012 08:53

Genus forms JV to expand its market share in China

Genus, a global animal genetics company, has said that its porcine genetics division, PIC, has signed a joint venture (JV) agreement with Shaanxi Yangling BeSun Agricultural Group, an integrated pork producer in China, to partner in the operation of a large 4,250 sow nucleus farm in China's Shaanxi

Read more
24 Jul 2012 08:15

Tuesday broker round-up

Aberdeen Asset Management: Societe Generale upgrades to buy from hold. Aggreko: S&P Equity Research upgrades to buy. BT Group: Societe Generale raises target from 210p to 220p, hold rating kept. CareTech: Canaccord Genuity ups target from 166p to 194p, buy rating kept. Carpetright: Merchant Secu

Read more
4 Jul 2012 07:34

London pre-open: Small declines forecast for FTSE

City sources predict the FTSE 100 will open down 12 points from yesterday's close of 5,688, with little guidance from the US following a half day of trading. Echoing statements made by sector peer Persimmon on Tuesday, house builder Taylor Wimpey said the first half of 2012 was a stable one for th

Read more
4 Jul 2012 07:08

Genus comes in on track

Genus, the global animal genetics company, said its full year figures would be in line with expectations after a good performance over the last two months. The company said pricing had remained firm, with adjusted operating profit improving in line with expectations despite increasing investment in

Read more
3 Jul 2012 17:56

Wednesday preview: Carillion, Genus, Topps Tiles

Tomorrow is Independence Day in the USA, so US markets will be closed but there should be plenty of news back in Blighty to keep traders occupied. Support services firm Carillion brings out a pre-close trading statement. Broker Peel Hunt says it is concerned that Middle East construction, which acc

Read more
3 May 2012 08:33

Genus aims to pig out in China

Pig and bovine semen seller Genus says customers have faced modest pressure in March and April but the first four months of the year have proceeded broadly in line with expectations. Genus's business model is based on providing the best genes to each market to increase productivity both in meat vol

Read more
14 Mar 2012 15:32

Genus Finance Director sells 43,000 shares

John Worby, Group Finance Director of Genus, the FTSE 250 animal genetics firm, has sold 43,000 shares, half of the amount he vested earlier this month. Worby sold 43,261 shares at 1,318.41p each for a total of £570,357. The sale was made further to the vesting of 86,523 conditional nil-cost share

Read more
21 Feb 2012 16:04

SSE director sells 1,000 shares

Jim McPhillimy, the Managing Director of Group Services at energy firm SSE, has sold off 1,000 shares in the firm for 1,289.00p each. The sale comes three weeks after the company said it was on course to deliver an increase in the dividend per share and an increase in pre-tax profits for the financ

Read more
21 Feb 2012 09:00

Tuesday broker round-up - UPDATE

Admiral: Nomura reiterates buy recommendation and 1,100p target; Credit Suisse upgrades to outperform from neutral, lifts target from 1,100p to 1,300p. Morrison: Goldman Sachs adds to conviction sell list. Petropavlovsk: Nomura upgrades from reduce to neutral, target upped from 860p to 910p. Aber

Read more
21 Feb 2012 07:35

Emerging markets boost sales at Genus

Strong growth in sales volumes in Asia has seen animal genetics firm Genus increase revenue by almost a tenth in the first half of its financial year. Furthermore, after reviewing its dividend policy last year, the firm has decided to start paying an interim dividend for the first time this year. T

Read more
20 Feb 2012 18:16

Tuesday preview: Devro, Genus, public sector finances

Profits from sausage skin maker Devro for 2011 will be served up as a smaller portion, with the group having disposed of its German distribution business, Devro GmbH, at the end of September. Profit before tax is expected to dive to £41.1m from £55.2m in 2010, on sales down to £226.6m from £237.0m

Read more
17 Feb 2012 09:09

Friday broker round-up -UPDATE

Ashmore: HSBC downgrades to underperform from neutral. Schroders: Citi downgrades to sell from neutral. Barclays: AlphaValue downgrades to reduce from add and lowers target to 243.9p from 283.4p. Tesco: Nomura reduces target from 500p to 430p, buy rating unchanged. InterContinental Hotels: UBS

Read more
22232425262728293031

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.